<?xml version="1.0" encoding="UTF-8"?>
<ref id="B126-ijms-21-01511">
 <label>126.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mossler</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Groiss</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wolzt</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wolschek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Seipelt</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Muster</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Phase I/II Trial of a Replication-Deficient Trivalent Influenza Virus Vaccine Lacking NS1</article-title>
  <source>Vaccine</source>
  <year>2013</year>
  <volume>31</volume>
  <fpage>6194</fpage>
  <lpage>6200</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.10.061</pub-id>
  <pub-id pub-id-type="pmid">24183981</pub-id>
 </element-citation>
</ref>
